Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-21

Clinical Trial Update: Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes [NA]

View source ↗

Summary

Clinical trial comparing a sensor-augmented insulin pump to multiple daily injections using degludec as basal insulin in adults with Type 1 diabetes; study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Degludec (degludec)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria Careggi | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED | Results posted: 2022-07-21